Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

GSK – GlaxoSmithKline plc

GSK plc
GSK
$38.58
Name : GSK plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $78,057,758,720.00
EPSttm : 2.08
finviz dynamic chart for GSK
GSK plc
$38.58
0.08%
$0.03

Float Short %

0.81

Margin Of Safety %

28

Put/Call OI Ratio

0.75

EPS Next Q Diff

0.21

EPS Last/This Y

EPS This/Next Y

0.5

Price

38.55

Target Price

44.23

Analyst Recom

3

Performance Q

0.16

Relative Volume

0.89

Beta

0.51

Ticker: GSK




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02GSK41.660.541.42115249
2025-06-03GSK40.470.561.23117764
2025-06-04GSK40.80.591.76124734
2025-06-05GSK41.150.601.76126308
2025-06-06GSK41.190.630.41134476
2025-06-09GSK40.870.580.73128629
2025-06-10GSK41.320.590.53130188
2025-06-11GSK41.620.590.28130747
2025-06-12GSK42.470.590.32131499
2025-06-13GSK40.840.597.40132255
2025-06-16GSK40.510.6510.79135454
2025-06-17GSK39.720.750.63143937
2025-06-18GSK38.640.741.02146437
2025-06-20GSK38.040.835.84151584
2025-06-23GSK38.260.780.74126906
2025-06-24GSK38.690.790.35128819
2025-06-25GSK38.280.741.43133840
2025-06-26GSK38.560.760.28137710
2025-06-27GSK38.560.751.46139421
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02GSK41.663.36143.34.30
2025-06-03GSK40.463.35803.34.30
2025-06-04GSK40.803.36315.74.30
2025-06-05GSK41.153.36116.04.30
2025-06-06GSK41.193.36004.24.30
2025-06-09GSK40.863.36007.04.30
2025-06-10GSK41.313.36204.74.30
2025-06-11GSK41.623.36156.14.35
2025-06-12GSK42.493.36272.34.35
2025-06-13GSK40.833.85474.44.36
2025-06-16GSK40.513.86267.94.36
2025-06-17GSK39.713.86241.34.36
2025-06-18GSK38.643.85853.94.36
2025-06-20GSK38.073.85822.04.36
2025-06-23GSK38.253.86204.44.36
2025-06-24GSK38.683.86107.64.36
2025-06-25GSK38.283.85824.14.36
2025-06-26GSK38.573.86269.94.36
2025-06-27GSK38.553.86131.94.36
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02GSK0-4.500.83
2025-06-03GSK0-4.500.83
2025-06-04GSK0-4.500.83
2025-06-05GSK0-4.500.83
2025-06-06GSK0-4.500.83
2025-06-09GSK0-4.560.83
2025-06-10GSK0-4.560.83
2025-06-11GSK0-4.560.82
2025-06-12GSK0-4.560.82
2025-06-13GSK0-4.560.82
2025-06-16GSK0-4.500.82
2025-06-17GSK0-4.500.82
2025-06-18GSK0-4.500.82
2025-06-20GSK0-4.500.82
2025-06-23GSK0-5.200.82
2025-06-24GSK0-5.200.82
2025-06-25GSK0-5.200.82
2025-06-26GSK0-5.200.81
2025-06-27GSK0-5.200.81
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

1.13

Avg. EPS Est. Current Quarter

1.16

Avg. EPS Est. Next Quarter

1.34

Insider Transactions

Institutional Transactions

-5.2

Beta

0.51

Average Sales Estimate Current Quarter

7920

Average Sales Estimate Next Quarter

8230

Fair Value

49.5

Quality Score

87

Growth Score

71

Sentiment Score

55

Actual DrawDown %

20.2

Max Drawdown 5-Year %

-39.3

Target Price

44.23

P/E

20.03

Forward P/E

7.82

PEG

2.04

P/S

1.94

P/B

4.31

P/Free Cash Flow

12.32

EPS

1.93

Average EPS Est. Cur. Y​

4.36

EPS Next Y. (Est.)

4.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.89

Relative Volume

0.89

Return on Equity vs Sector %

-1.6

Return on Equity vs Industry %

-9.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

6131.9
GSK plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 68629
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today
news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025
marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance
stock history GSK – GlaxoSmithKline plc invest stock market
stock prices GSK premarket after hours
ticker GSK fair value insiders trading